217 filings
8-K
NVCR
NovoCure Ltd
10 Jun 24
Departure of Directors or Certain Officers
4:09pm
8-K
NVCR
NovoCure Ltd
20 May 24
Regulation FD Disclosure
8:01am
10-Q
2024 Q1
NVCR
NovoCure Ltd
Quarterly report
2 May 24
7:01am
8-K
NVCR
NovoCure Ltd
2 May 24
Novocure Reports First Quarter 2024 Financial Results
7:01am
DEFA14A
NVCR
NovoCure Ltd
22 Apr 24
Additional proxy soliciting materials
4:02pm
8-K
6cc9vfkeq5k2kgbbsj
27 Mar 24
Regulation FD Disclosure
7:00am
S-8
a4u3wq tygp3wumicj
22 Feb 24
Registration of securities for employees
7:11am
8-K
dex68ew wie
22 Feb 24
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
7:06am
8-K
nmpd mcv5kgz984y3
18 Jan 24
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
7:01am
8-K
bjw85oaalzj7207lcqn
9 Jan 24
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
7:00am
8-K
dddzdc
8 Jan 24
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
7:10am
8-K
s8fnxq4
4 Jan 24
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
4:10pm
8-K
0fg0d35f
28 Nov 23
Regulation FD Disclosure
7:30am
8-K
dx6u0rzcy7 ptjnp
26 Oct 23
Novocure Reports Third Quarter 2023 Financial Results
7:03am
8-K
sar43 bxjrdxbo
28 Aug 23
Regulation FD Disclosure
7:00am
8-K
8wl dss710101lo4
27 Jul 23
Novocure Reports Second Quarter 2023 Financial Results
7:03am